Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Aberrant recruitment and activation of T cells in diabetic nephropathy.

    Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH.

    Am J Nephrol. 2012;35(2):164-74. Epub 2012 Jan 25.

    PMID:
    22286547
    [PubMed - in process]
    2.

    Genetic and functional effects of membrane metalloendopeptidase on diabetic nephropathy development.

    Zhang D, Gu T, Forsberg E, Efendic S, Brismar K, Gu HF.

    Am J Nephrol. 2011;34(5):483-90. Epub 2011 Oct 22.

    PMID:
    22024547
    [PubMed - indexed for MEDLINE]
    3.

    Use of diffusion tensor MRI to identify early changes in diabetic nephropathy.

    Lu L, Sedor JR, Gulani V, Schelling JR, O'Brien A, Flask CA, MacRae Dell K.

    Am J Nephrol. 2011;34(5):476-82. Epub 2011 Oct 18.

    PMID:
    22024476
    [PubMed - indexed for MEDLINE]
    4.

    Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease.

    Zhou L, Liu F, Huang XR, Liu F, Chen H, Chung AC, Shi J, Wei L, Lan HY, Fu P.

    Am J Nephrol. 2011;34(5):468-75. Epub 2011 Oct 4.

    PMID:
    21986457
    [PubMed - indexed for MEDLINE]
    5.

    Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man.

    Coughlan MT, Patel SK, Jerums G, Penfold SA, Nguyen TV, Sourris KC, Panagiotopoulos S, Srivastava PM, Cooper ME, Burrell LM, Macisaac RJ, Forbes JM.

    Am J Nephrol. 2011;34(4):347-55. Epub 2011 Aug 26.

    PMID:
    21876347
    [PubMed - indexed for MEDLINE]
    6.

    Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.

    Lim AK, Ma FY, Nikolic-Paterson DJ, Ozols E, Young MJ, Bennett BL, Friedman GC, Tesch GH.

    Am J Nephrol. 2011;34(4):337-46. Epub 2011 Aug 26.

    PMID:
    21876346
    [PubMed - indexed for MEDLINE]
    7.

    Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.

    Goto S, Fujii H, Kono K, Nakai K, Hamada Y, Yamato H, Shinohara M, Kitazawa R, Kitazawa S, Nishi S, Fukagawa M.

    Am J Nephrol. 2011;34(3):281-90. Epub 2011 Aug 9.

    PMID:
    21829007
    [PubMed - indexed for MEDLINE]
    8.

    Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.

    Zhao X, Zhang Y, Li L, Mann D, Imig JD, Emmett N, Gibbons G, Jin LM.

    Am J Nephrol. 2011;34(3):268-80. Epub 2011 Aug 4.

    PMID:
    21822010
    [PubMed - indexed for MEDLINE]
    9.

    Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.

    Coughlan MT, Forbes JM.

    Am J Nephrol. 2011;34(1):9-17. Epub 2011 Jun 6.

    PMID:
    21654162
    [PubMed - indexed for MEDLINE]
    10.

    The role of high-mobility group box-1 protein in the development of diabetic nephropathy.

    Kim J, Sohn E, Kim CS, Jo K, Kim JS.

    Am J Nephrol. 2011;33(6):524-9. Epub 2011 May 23.

    PMID:
    21606643
    [PubMed - indexed for MEDLINE]
    11.

    Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes.

    Murea M, Lu L, Ma L, Hicks PJ, Divers J, McDonough CW, Langefeld CD, Bowden DW, Freedman BI.

    Am J Nephrol. 2011;33(6):502-9. Epub 2011 May 5.

    PMID:
    21546767
    [PubMed - indexed for MEDLINE]
    12.

    Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study.

    Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL, Duggirala R, Divers J, Abboud H, Adler SG, Arar NH, Horvath A, Elston RC, Bowden DW, Guo X, Ipp E, Kao WH, Kimmel PL, Knowler WC, Meoni LA, Molineros J, Nelson RG, Pahl MV, Parekh RS, Rasooly RS, Schelling JR, Shah VO, Smith MW, Winkler CA, Zager PG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group.

    Am J Nephrol. 2011;33(5):381-9. Epub 2011 Mar 31.

    PMID:
    21454968
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation.

    Li H, Zhang L, Wang F, Shi Y, Ren Y, Liu Q, Cao Y, Duan H.

    Am J Nephrol. 2011;33(4):289-97. Epub 2011 Mar 8.

    PMID:
    21389693
    [PubMed - indexed for MEDLINE]
    14.

    Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.

    Tien KJ, Tu ST, Chou CW, Yang CY, Hsiao JY, Shin SJ, Chen HC, Hsieh MC.

    Am J Nephrol. 2011;33(3):231-8. Epub 2011 Feb 23.

    PMID:
    21346330
    [PubMed - indexed for MEDLINE]
    15.

    Podocyte detachment in type 2 diabetic nephropathy.

    Weil EJ, Lemley KV, Yee B, Lovato T, Richardson M, Myers BD, Nelson RG.

    Am J Nephrol. 2011;33 Suppl 1:21-4. Epub 2011 Jun 10.

    PMID:
    21659731
    [PubMed - indexed for MEDLINE]
    16.

    TEM stereometric analyses of glomeruli in aging OVE26 transgenic diabetic mice.

    Teiken JM, Epstein PN, Carlson EC.

    Am J Nephrol. 2011;33 Suppl 1:8-14. Epub 2011 Jun 10.

    PMID:
    21659729
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk